Kenvue (KVUE)

NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-15

$18.91+1.29%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Kenvue’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

0.0%

+10% or more+5%0%−5%−10% or less

1.25 → 1.25 EPS · FY ending Dec 28, 2027 · 8 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 8; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

5 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Smooth CFO transition maintaining financial stability	A supporting condition in Kenvue's published investment case. The stated target is No major financial disruptions or guidance cuts due to CFO change.	Under Pressure	significant financial instability or guidance cuts linked to CFO transition	Qualitative: CFO transition ongoing, no guidance cuts reported CFO Amit Banati stepped down in April 2026; Heather Howlett serving as interim. No guidance cuts or financial disruptions reported. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Management announced the CFO transition with Amit Banati stepping down and Heather Howlett serving as interim CFO. This leadership change is recent, and management is focused on maintaining financial stability during the transition. Delivery assessment Oct 15, 2026
EPS around $1.02 for 2025	Profit margins remain stable with EPS around $1.02 for 2025.	Intact	EPS falls below $1.00 for 2025	Diluted EPS: $0.24 per share FY2026-Q2; GAAP. Published target: ~$1.02 EPS for 2025. Target period ends 2025-12-31; this observation covers 2026-Q2. Source published Aug 6, 20260.24 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 28, 2026 Source: company_financial_results. Reference: b688957f-03fa-4509-b284-93423589e852. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Net sales growth near 4.5% YoY	A primary condition in Kenvue's published investment case. The stated target is >=4.5% YoY net sales growth.	Broken	net sales growth falls below 3% YoY	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Progress on 2026 restructuring initiative	A supporting condition in Kenvue's published investment case. The stated target is Progress score >= 40%.	Intact	progress score falls below 30% by end 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. The 2026 Restructuring Initiative aims to optimize the operating model and transform the supply chain, with expected pre-tax charges of approximately $250 million in 2026. Management has reiterated this initiative consistently, and the financial disclosures confirm the planned restructuring expenses, indicating ongoing delivery on this priority. Delivery assessment Oct 15, 2026
Organic sales growth at or above 0.7% quarterly	Kenvue grows sales about 4.5% yearly, driven by organic growth and market expansion.	Intact	organic sales growth falls below 0.7% quarterly	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-28 · fmp

FY2027 EPS$1.25

$1.26 → $1.25 · observed estimates

FY2027 revenue$15.97B

$16.02B → $15.97B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.26	$16,017,673,671	9 / 10
2026-07-25	$1.26	$16,017,673,671	9 / 10
2026-07-26	$1.26	$16,017,673,671	9 / 10
2026-07-27	$1.26	$16,017,673,671	9 / 10
2026-07-28	$1.26	$16,017,673,672	9 / 10
2026-07-29	$1.26	$16,017,673,672	9 / 10
2026-07-30	$1.26	$16,017,673,672	9 / 10
2026-07-31	$1.26	$16,017,673,672	9 / 10
2026-08-01	$1.26	$16,017,673,672	9 / 10
2026-08-02	$1.26	$16,017,673,672	9 / 10
2026-08-03	$1.26	$16,017,673,672	9 / 10
2026-08-04	$1.26	$16,017,673,672	9 / 10
2026-08-05	$1.26	$16,017,673,672	9 / 10
2026-08-06	$1.26	$16,017,673,672	9 / 10
2026-08-07	$1.26	$16,017,673,672	8 / 10
2026-08-08	$1.26	$16,017,673,672	8 / 10
2026-08-09	$1.26	$16,017,673,672	8 / 10
2026-08-10	$1.26	$16,017,673,672	8 / 10
2026-08-12	$1.26	$16,017,673,672	8 / 10
2026-08-13	$1.26	$16,017,673,672	8 / 10
2026-08-14	$1.26	$16,017,673,672	8 / 10
2026-08-15	$1.26	$16,017,673,672	8 / 10
2026-08-16	$1.26	$16,017,673,672	8 / 10
2026-08-17	$1.26	$16,017,673,672	8 / 10
2026-08-18	$1.26	$16,017,673,672	8 / 10
2026-08-19	$1.26	$16,017,673,672	8 / 10
2026-08-20	$1.24	$15,962,072,866	8 / 10
2026-08-21	$1.24	$15,962,072,866	8 / 10
2026-08-22	$1.24	$15,961,345,593	8 / 10
2026-08-23	$1.24	$15,961,345,593	8 / 10
2026-08-24	$1.24	$15,961,345,593	8 / 10
2026-08-25	$1.25	$15,968,639,694	8 / 10
2026-08-26	$1.25	$15,968,639,694	8 / 10
2026-08-27	$1.25	$15,968,639,694	8 / 10
2026-08-28	$1.25	$15,968,639,694	8 / 10
2026-08-29	$1.25	$15,968,639,694	8 / 10
2026-08-30	$1.25	$15,968,639,694	8 / 10
2026-08-31	$1.25	$15,968,639,694	8 / 10
2026-09-01	$1.25	$15,968,639,694	8 / 10
2026-09-02	$1.25	$15,968,639,694	8 / 10
2026-09-03	$1.25	$15,968,639,694	8 / 10
2026-09-04	$1.25	$15,968,639,694	8 / 10
2026-09-05	$1.25	$15,968,639,694	8 / 10
2026-09-06	$1.25	$15,968,639,694	8 / 10
2026-09-07	$1.25	$15,968,639,694	8 / 10
2026-09-08	$1.25	$15,968,639,694	8 / 10
2026-09-09	$1.25	$15,968,639,694	8 / 10
2026-09-10	$1.25	$15,968,639,694	8 / 10
2026-09-11	$1.25	$15,968,639,694	8 / 10
2026-09-12	$1.25	$15,968,639,694	8 / 10
2026-09-13	$1.25	$15,968,639,694	8 / 10
2026-09-14	$1.25	$15,968,639,694	8 / 10
2026-09-15	$1.25	$15,968,639,694	8 / 10
2026-09-16	$1.25	$15,968,639,694	8 / 10
2026-09-17	$1.25	$15,968,639,694	8 / 10
2026-09-18	$1.25	$15,968,639,694	8 / 10
2026-09-19	$1.25	$15,968,639,694	8 / 10
2026-09-20	$1.25	$15,968,639,694	8 / 10
2026-09-21	$1.25	$15,968,639,694	8 / 10
2026-09-22	$1.25	$15,968,639,694	8 / 10
2026-09-23	$1.25	$15,968,639,694	8 / 10
2026-09-24	$1.25	$15,968,639,694	8 / 10
2026-09-25	$1.25	$15,968,639,694	8 / 10
2026-09-26	$1.25	$15,968,639,694	8 / 10
2026-09-27	$1.25	$15,968,639,694	8 / 10
2026-09-28	$1.25	$15,968,639,694	8 / 10
2026-09-29	$1.25	$15,968,639,694	8 / 10
2026-09-30	$1.25	$15,968,639,694	8 / 10
2026-10-01	$1.25	$15,968,639,694	8 / 10
2026-10-02	$1.25	$15,968,639,694	8 / 10
2026-10-03	$1.25	$15,968,639,694	8 / 10
2026-10-04	$1.25	$15,968,639,694	8 / 10
2026-10-05	$1.25	$15,968,639,694	8 / 10
2026-10-06	$1.25	$15,968,639,694	8 / 10
2026-10-07	$1.25	$15,968,639,694	8 / 10
2026-10-08	$1.25	$15,968,639,694	8 / 10
2026-10-09	$1.25	$15,968,639,694	8 / 10
2026-10-10	$1.25	$15,968,639,694	8 / 10
2026-10-11	$1.25	$15,968,639,694	8 / 10
2026-10-12	$1.25	$15,968,639,694	8 / 10
2026-10-13	$1.25	$15,968,639,694	8 / 10
2026-10-14	$1.25	$15,968,639,694	8 / 10
2026-10-15	$1.25	$15,968,639,694	8 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	2	12
2026-06-01	2	12
2026-07-01	2	12
2026-08-01	2	12
2026-09-01	2	12
2026-10-01	2	12

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 2 Buy / Strong Buy · 12 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 16–Oct 15 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Smooth CFO transition maintaining financial stabilityPublished status: Under Pressure
EPS around $1.02 for 2025Diluted EPS: $0.24 per share
Net sales growth near 4.5% YoYPublished status: Broken
Progress on 2026 restructuring initiativeDirect metric needs a verified mapping
Organic sales growth at or above 0.7% quarterlyDirect metric needs a verified mapping

Next proof point

Nov 2, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

5 of 5 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-13.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Kenvue outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

KVUE represents a consumer staples investment with a focus on stabilizing growth and operational improvements. The current thesis state is intact, but recent changes in confidence indicate a cautious outlook.

What's priced into Kenvue

The market appears to have a neutral valuation stance, with KVUE priced as cheap compared to peers. There is a slight expectations gap, suggesting that the market may not fully account for potential risks or rewards in the near term.

What the fundamentals likely do

Fundamentals are likely to remain stable, supported by recent strong financial performance and a recovery in organic sales growth. However, there is a moderate risk due to recent earnings misses and ongoing management transitions.

What Kenvue hinges on

The thesis hinges on management's ability to complete the merger with Kimberly-Clark and optimize the operating model. Additionally, external factors like inflation trends and job market performance will significantly impact KVUE's trajectory.